Wenger Vieli advised Sygnum Bank AG on the deal. Mayer Brown represented Sun Hung Kai & Co. Limited. Sygnum Bank AG, the world’s first digital asset...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Sequotech Group on the deal. Sequotech Group announced the acquisition of UDITIS SA, a company also active in the domain of information systems. The acquisition...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Kandou on the deal. Kandou, a fabless semiconductor company, announced its USD 75m Series D financing round. Kandou is the innovative leader in...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Xeltis on the deal. Xeltis is a pioneering medtech firm developing medical devices enabling cardiovascular restoration. The Swiss/Dutch university spin-off landed a €15...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Molten Ventures on the deal. Hypertension health-tech firm Aktiia raised USD 17.5M in a Series A funding. The round was led by UK-based...
You must be a Standard 1 Year member to access this content.
Homburger advised Credit Suisse (Switzerland) Ltd. in connection with the financing of the acquisition. Bär & Karrer acted as legal advisor to the sellers in this...
You must be a Standard 1 Year member to access this content.
Renzenbrink & Partner, Wenger Vieli and Milbank advised Klingel medical metal on the deal. Bär & Karrer acted as legal advisor to the sellers in this...
You must be a Standard 1 Year member to access this content.
Homburger advised HV Capital on the deal. Wenger Vieli advised Archlet. Archlet AG, a spin-off of ETH Zurich that develops and markets data-driven sourcing software, announced...
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey advised Norstat Group on the deal. Wenger Vieli Ltd advised the shareholders of TestingTime AG. The Norwegian firm Norstat has completed a takeover...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised lead investor Revaia on the deal. Wenger Vieli advised Frontify. Frontify AG, a leading provider of brand management software, raised an additional USD...
You must be a Standard 1 Year member to access this content.
VISCHER advised the sellers on this transaction. Wenger Vieli advised Atlas Antibodies. The shareholders of the evitria Group have sold the evitria Group to Atlas Antibodies,...
You must be a Standard 1 Year member to access this content.
